BioStem Technologies' CEO and COO Invest $1 Million by Exercising Stock Options
BioStem Technologies (BSEM) announced that its Chair and CEO, Jason Matuszewski, along with COO Andrew Van Vurst, each exercised stock options to purchase 250,000 shares at $2.00 per share. This resulted in the acquisition of a total of 500,000 shares for approximately $1 million. The move signals confidence from top executives in BioStem's future performance and aligns their interests with shareholders. The company has also recently raised its revenue outlook to between $26M-$29M for the year ending December 31, 2026, while aiming to transfer manufacturing operations by mid-2027. This investment comes amid a broader context of strategic initiatives and financial updates from BioStem Technologies.
Tickers: $BSEM